TREPROSTINIL

TREPROSTINIL was reported 127765 times

TREPROSTINIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE WIRELESS COMMUNICATION ISSUE 256 0.9884
1 INFUSION SITE PUSTULE 110 0.8594
2 DEVICE MAINTENANCE ISSUE 472 0.8027
3 UNEVALUABLE DEVICE ISSUE 66 0.7416
4 BENDOPNOEA 152 0.6909
5 INFUSION SITE INFECTION 1549 0.6660
6 ADMINISTRATION SITE ODOUR 44 0.5789
7 INFUSION SITE SCAB 66 0.5366
8 INFUSION SITE DISCHARGE 938 0.5345
9 INFUSION SITE WARMTH 597 0.4869
10 INFUSION SITE IRRITATION 596 0.4638
11 INFUSION SITE CELLULITIS 243 0.4602
12 INFUSION SITE INJURY 81 0.4602
13 INTRACARDIAC PRESSURE INCREASED 40 0.4545
14 INFUSION SITE PAIN 5800 0.4496
15 INFUSION SITE INDURATION 662 0.4464
16 INFUSION SITE HAEMORRHAGE 1441 0.4376
17 PATIENT DISSATISFACTION WITH DEVICE 108 0.4286
18 INFUSION SITE OEDEMA 356 0.4258
19 OXYGEN CONSUMPTION INCREASED 994 0.4156
20 INFUSION SITE INFLAMMATION 285 0.4037
21 INFUSION SITE ABSCESS 202 0.4008
22 INFUSION SITE ERYTHEMA 3361 0.3983
23 INFUSION SITE VESICLES 200 0.3802
24 WALKING DISTANCE TEST ABNORMAL 144 0.3683
25 CATHETER SITE SCAB 38 0.3551
26 CATHETER SITE VESICLES 69 0.3538
27 CATHETER SITE PRURITUS 304 0.3462
28 INFUSION SITE DISCOLOURATION 301 0.3420
29 INFUSION SITE HYPERSENSITIVITY 41 0.3417
30 CATHETER SITE IRRITATION 111 0.3333
31 DEVICE INFUSION ISSUE 815 0.3284
32 POST-TUSSIVE VOMITING 51 0.3129
33 PULMONARY ARTERIAL HYPERTENSION 4511 0.3110
34 PULMONARY HYPERTENSIVE CRISIS 84 0.3100
35 INFUSION SITE SWELLING 1939 0.3078
36 VASCULAR DEVICE OCCLUSION 102 0.3009
37 CATHETER SITE WARMTH 49 0.3006
38 PULMONARY ARTERIAL PRESSURE ABNORMAL 86 0.2986
39 INFUSION SITE NODULE 284 0.2955
40 CATHETER SITE RASH 132 0.2920
41 PULMONARY ARTERIAL PRESSURE INCREASED 476 0.2920
42 INFUSION SITE DISCOMFORT 299 0.2883
43 ACUTE RIGHT VENTRICULAR FAILURE 49 0.2882
44 CATHETER SITE DISCHARGE 313 0.2785
45 CATHETERISATION CARDIAC ABNORMAL 74 0.2741
46 CATHETER SITE ERYTHEMA 551 0.2572
47 INFUSION SITE RASH 337 0.2454
48 INFUSION SITE PRURITUS 772 0.2445
49 RIGHT VENTRICULAR FAILURE 1650 0.2352
50 TRANSPLANT EVALUATION 114 0.2244
51 COR PULMONALE CHRONIC 41 0.2181
52 INFUSION SITE REACTION 652 0.2181
53 CATHETER SITE PAIN 564 0.2172
54 VASCULAR DEVICE INFECTION 979 0.2156
55 INFUSION SITE SCAR 94 0.2122
56 CATHETER SITE SWELLING 197 0.2105
57 CATHETER MANAGEMENT 184 0.2047
58 VENTILATION PERFUSION MISMATCH 57 0.2028
59 CARDIAC FAILURE HIGH OUTPUT 47 0.1950
60 DEVICE ALARM ISSUE 354 0.1948
61 DIZZINESS EXERTIONAL 148 0.1947
62 CATHETER SITE EXTRAVASATION 73 0.1830
63 CATHETER SITE HAEMORRHAGE 436 0.1741
64 DERMATITIS CONTACT 1983 0.1737
65 DEVICE PROGRAMMING ERROR 53 0.1672
66 PULMONARY VENO-OCCLUSIVE DISEASE 117 0.1671
67 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 90 0.1604
68 DEVICE ELECTRICAL FINDING 109 0.1540
69 HYPERVOLAEMIA 760 0.1536
70 DYSPNOEA AT REST 430 0.1483
71 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 44 0.1388
72 PULMONARY HYPERTENSION 2890 0.1386
73 CATHETER SITE INFLAMMATION 78 0.1385
74 DEVICE RELATED SEPSIS 279 0.1385
75 INFUSION SITE MASS 149 0.1371
76 PAIN IN JAW 3670 0.1294
77 DEVICE CONNECTION ISSUE 272 0.1288
78 RIGHT VENTRICULAR DYSFUNCTION 139 0.1260
79 SEASONAL ALLERGY 1761 0.1243
80 SCLERODERMA 452 0.1242
81 DEVICE POWER SOURCE ISSUE 350 0.1198
82 INFUSION SITE HAEMATOMA 57 0.1197
83 DYSPNOEA EXERTIONAL 4491 0.1191
84 FLUID OVERLOAD 1698 0.1166
85 LUNG TRANSPLANT 408 0.1151
86 CATHETER REMOVAL 40 0.1120
87 CENTRAL VENOUS CATHETERISATION 334 0.1106
88 RESPIRATORY TRACT IRRITATION 113 0.1082
89 INJECTION SITE INFECTION 347 0.1055
90 INJECTION SITE PUSTULE 40 0.1050
91 HAEMOGLOBIN INCREASED 468 0.1025
92 SUTURE RELATED COMPLICATION 72 0.1018
93 DRUG TOLERANCE DECREASED 286 0.1017
94 DEPENDENCE ON OXYGEN THERAPY 50 0.1014
95 CATHETER SITE RELATED REACTION 76 0.1013
96 DEVICE RELATED INFECTION 1559 0.1012
97 FLUID RETENTION 5150 0.1011
98 INFUSION SITE BRUISING 212 0.0981
99 DRUG TITRATION ERROR 253 0.0979
100 CATHETER PLACEMENT 180 0.0970
101 COR PULMONALE 89 0.0932
102 OXYGEN SATURATION DECREASED 5148 0.0915
103 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 92 0.0914
104 PURULENT DISCHARGE 387 0.0905
105 INJECTION SITE DISCHARGE 484 0.0899
106 RIGHT VENTRICULAR DILATATION 52 0.0898
107 CATHETERISATION CARDIAC 391 0.0881
108 SICKLE CELL ANAEMIA 56 0.0868
109 PATIENT DISSATISFACTION WITH TREATMENT 162 0.0840
110 CATHETER SITE INFECTION 314 0.0829
111 PARACENTESIS 49 0.0797
112 SUTURE RUPTURE 55 0.0794
113 CHRONIC RESPIRATORY FAILURE 94 0.0778
114 INFUSION SITE URTICARIA 50 0.0746
115 OXYGEN SATURATION ABNORMAL 211 0.0743
116 PULMONARY PAIN 210 0.0719
117 RESPIRATION ABNORMAL 491 0.0712
118 NOCTURNAL DYSPNOEA 88 0.0690
119 CARBON DIOXIDE INCREASED 94 0.0689
120 ECHOCARDIOGRAM ABNORMAL 96 0.0686
121 PRODUCT AFTER TASTE 64 0.0671
122 THROMBOSIS IN DEVICE 219 0.0667
123 JUGULAR VEIN DISTENSION 37 0.0653
124 DIZZINESS POSTURAL 630 0.0649
125 THERAPY NON-RESPONDER 2818 0.0626
126 ADMINISTRATION SITE PAIN 71 0.0616
127 DEVICE DAMAGE 49 0.0615
128 LOCALISED OEDEMA 282 0.0609
129 DEVICE RELATED THROMBOSIS 59 0.0598
130 THROAT IRRITATION 2665 0.0593
131 EXERCISE TOLERANCE DECREASED 336 0.0583
132 BRAIN NATRIURETIC PEPTIDE INCREASED 178 0.0577
133 WRONG DOSE 131 0.0541
134 PNEUMONIA INFLUENZAL 64 0.0537
135 OXYGEN SUPPLEMENTATION 38 0.0514
136 HYPOXIA 1802 0.0511
137 CHOKING SENSATION 280 0.0507
138 BLOOD PRESSURE SYSTOLIC DECREASED 229 0.0503
139 RHINOVIRUS INFECTION 194 0.0498
140 INJECTION SITE SCAB 47 0.0488
141 PRODUCTIVE COUGH 2324 0.0486
142 RALES 277 0.0477
143 DEVICE FAILURE 720 0.0472
144 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 66 0.0470
145 RESPIRATORY TRACT CONGESTION 747 0.0470
146 DEVICE LOOSENING 40 0.0462
147 PAINFUL RESPIRATION 109 0.0451
148 NASAL CONGESTION 2637 0.0448
149 DEVICE OCCLUSION 631 0.0448
150 OEDEMA 2429 0.0447
151 CARDIAC OUTPUT DECREASED 39 0.0442
152 INFUSION SITE EXTRAVASATION 273 0.0438
153 COUGH 12264 0.0437
154 PARANASAL SINUS HYPERSECRETION 166 0.0435
155 DEVICE DISLOCATION 1885 0.0433
156 THERAPY CHANGE 416 0.0423
157 PRODUCT LEAKAGE 233 0.0415
158 HAEMOPTYSIS 1155 0.0414
159 PARANASAL SINUS DISCOMFORT 153 0.0404
160 PRODUCT ADMINISTRATION INTERRUPTED 317 0.0403
161 VASODILATATION 98 0.0389
162 INCORRECT DRUG ADMINISTRATION RATE 165 0.0387
163 DYSPNOEA 21943 0.0387
164 FLUSHING 3923 0.0386
165 COMPLICATION ASSOCIATED WITH DEVICE 557 0.0383
166 PERICARDIAL EFFUSION 884 0.0382
167 MIDDLE EAR EFFUSION 82 0.0371
168 ACUTE RESPIRATORY FAILURE 701 0.0364
169 DEVICE PHYSICAL PROPERTY ISSUE 272 0.0355
170 OXYGEN THERAPY 58 0.0353
171 NASAL DRYNESS 214 0.0341
172 EPISTAXIS 2540 0.0339
173 HAEMATOLOGICAL INFECTION 83 0.0339
174 CARDIAC DISCOMFORT 68 0.0337
175 PRESYNCOPE 812 0.0334
176 SPUTUM DISCOLOURED 315 0.0332
177 SINUS CONGESTION 446 0.0330
178 EAR CONGESTION 89 0.0328
179 CARDIAC ABLATION 58 0.0324
180 DECREASED ACTIVITY 348 0.0322
181 SECRETION DISCHARGE 396 0.0316
182 ATRIAL FLUTTER 249 0.0312
183 LOWER RESPIRATORY TRACT CONGESTION 53 0.0311
184 WEIGHT FLUCTUATION 326 0.0311
185 BREATH SOUNDS ABNORMAL 153 0.0310
186 IDIOPATHIC PULMONARY FIBROSIS 122 0.0308
187 OEDEMA PERIPHERAL 3705 0.0304
188 INJECTION SITE CELLULITIS 55 0.0296
189 HYPOTENSION 5902 0.0294
190 ASCITES 862 0.0293
191 OROPHARYNGEAL DISCOMFORT 264 0.0292
192 RESPIRATORY TRACT INFECTION VIRAL 68 0.0292
193 ORTHOPNOEA 93 0.0292
194 THERAPY PARTIAL RESPONDER 455 0.0291
195 DEVICE PLACEMENT ISSUE 104 0.0290
196 INTRA-ABDOMINAL FLUID COLLECTION 52 0.0290
197 SINUS DISORDER 574 0.0290
198 DRUG DOSE TITRATION NOT PERFORMED 53 0.0289
199 SYNCOPE 2888 0.0288
200 TRANSFUSION 300 0.0286
201 DEVICE OPERATIONAL ISSUE 123 0.0286
202 HEADACHE 17829 0.0284
203 MECHANICAL VENTILATION 54 0.0284
204 BLOOD PRESSURE DECREASED 1887 0.0284
205 RETCHING 605 0.0283
206 CHEST DISCOMFORT 2883 0.0281
207 INJECTION SITE OEDEMA 48 0.0279
208 CARDIAC FAILURE ACUTE 184 0.0276
209 DRY THROAT 279 0.0274
210 UPPER-AIRWAY COUGH SYNDROME 224 0.0272
211 PULMONARY OEDEMA 1209 0.0270
212 SENSITIVITY TO WEATHER CHANGE 142 0.0270
213 DEVICE KINK 98 0.0269
214 SINUS HEADACHE 158 0.0266
215 LIVER TRANSPLANT 96 0.0264
216 FAECES SOFT 192 0.0264
217 BLOOD ELECTROLYTES DECREASED 37 0.0260
218 CHEST PAIN 4804 0.0259
219 OROPHARYNGEAL PAIN 2243 0.0242
220 BLOOD IRON DECREASED 287 0.0242
221 WEIGHT ABNORMAL 58 0.0241
222 PNEUMONIA VIRAL 77 0.0241
223 PHYSICAL DECONDITIONING 62 0.0241
224 DEVICE LEAKAGE 1041 0.0240
225 BLOOD LOSS ANAEMIA 54 0.0238
226 BACTERAEMIA 282 0.0237
227 PRODUCT DEPOSIT 37 0.0237
228 HEAD DISCOMFORT 419 0.0236
229 INTERNAL HAEMORRHAGE 266 0.0233
230 EYE CONTUSION 49 0.0232
231 BLOOD CULTURE POSITIVE 68 0.0227
232 GASTROENTERITIS VIRAL 401 0.0222
233 GOUT 398 0.0222
234 PALPITATIONS 2588 0.0221
235 LUNG DISORDER 1082 0.0221
236 MYOCARDIAL NECROSIS MARKER INCREASED 37 0.0221
237 DIARRHOEA 14240 0.0220
238 UNINTENTIONAL MEDICAL DEVICE REMOVAL 250 0.0216
239 RESPIRATORY SYNCYTIAL VIRUS INFECTION 188 0.0216
240 SINUS PAIN 50 0.0214
241 FINE MOTOR SKILL DYSFUNCTION 62 0.0214
242 ENDOTRACHEAL INTUBATION 60 0.0214
243 PERIPHERAL SWELLING 3293 0.0214
244 EAR DISCOMFORT 219 0.0213
245 HEART RATE INCREASED 2099 0.0212
246 DEVICE INFORMATION OUTPUT ISSUE 164 0.0210
247 BLOOD POTASSIUM DECREASED 633 0.0210
248 DEVICE ISSUE 1883 0.0210
249 HEART RATE ABNORMAL 116 0.0208
250 BLOOD POTASSIUM ABNORMAL 55 0.0206
251 CYANOSIS 324 0.0206
252 MEDICAL DEVICE COMPLICATION 152 0.0205
253 DYSENTERY 38 0.0204
254 BLOOD PRESSURE ABNORMAL 405 0.0203
255 HAEMATOCRIT INCREASED 46 0.0202
256 CARDIAC FAILURE 1614 0.0201
257 TERMINAL STATE 134 0.0200
258 DIZZINESS 9884 0.0198
259 LEFT VENTRICULAR FAILURE 68 0.0197
260 RESPIRATORY FAILURE 1434 0.0196
261 CARDIAC FLUTTER 127 0.0196
262 HYPOPNOEA 66 0.0190
263 THROAT CLEARING 71 0.0189
264 DEVICE USE ERROR 650 0.0187
265 CLOSTRIDIUM DIFFICILE INFECTION 407 0.0186
266 COLONOSCOPY 41 0.0186
267 RHINORRHOEA 1195 0.0185
268 HAEMORRHOIDAL HAEMORRHAGE 90 0.0184
269 SLUGGISHNESS 185 0.0181
270 TRANSPLANT 43 0.0181
271 CARDIAC FAILURE CONGESTIVE 1434 0.0178
272 PNEUMONIA 5767 0.0178
273 GASTRIC INFECTION 68 0.0178
274 SUFFOCATION FEELING 44 0.0177
275 DISEASE COMPLICATION 81 0.0177
276 SARCOIDOSIS 84 0.0177
277 TREATMENT NONCOMPLIANCE 964 0.0176
278 PULMONARY HAEMORRHAGE 137 0.0175
279 RESPIRATORY DISTRESS 478 0.0173
280 ABDOMINAL DISTENSION 1807 0.0173
281 PULMONARY FIBROSIS 328 0.0171
282 PAIN IN EXTREMITY 5026 0.0170
283 HYPERCAPNIA 51 0.0169
284 INJECTION SITE IRRITATION 214 0.0168
285 FOOD POISONING 90 0.0168
286 STAPHYLOCOCCAL BACTERAEMIA 73 0.0168
287 SUPRAVENTRICULAR TACHYCARDIA 160 0.0167
288 ABDOMINAL DISCOMFORT 2751 0.0164
289 VIRAL INFECTION 544 0.0163
290 SKIN ABRASION 77 0.0163
291 DRUG INTOLERANCE 1561 0.0161
292 THERAPY CESSATION 827 0.0161
293 NAUSEA 12742 0.0161
294 GASTROINTESTINAL MOTILITY DISORDER 86 0.0161
295 CHOLECYSTITIS INFECTIVE 44 0.0158
296 HEART RATE IRREGULAR 356 0.0157
297 DEVICE MALFUNCTION 1100 0.0156
298 DEVICE USE ISSUE 272 0.0155
299 NASOPHARYNGITIS 2866 0.0155
300 DECREASED APPETITE 3605 0.0155
301 INTERNATIONAL NORMALISED RATIO ABNORMAL 53 0.0154
302 PNEUMOTHORAX 244 0.0154
303 CELLULITIS 770 0.0153
304 FACE INJURY 58 0.0153
305 INJECTION SITE ABSCESS 38 0.0153
306 DYSPEPSIA 1500 0.0152
307 PORTAL HYPERTENSION 47 0.0152
308 EMERGENCY CARE 46 0.0152
309 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 790 0.0151
310 NASAL DISCOMFORT 120 0.0151
311 CARDIOGENIC SHOCK 217 0.0151
312 PULSELESS ELECTRICAL ACTIVITY 63 0.0151
313 HEAD INJURY 476 0.0150
314 LOCALISED INFECTION 361 0.0149
315 CARDIOMEGALY 183 0.0149
316 ENDOCARDITIS 76 0.0148
317 GENERALISED OEDEMA 183 0.0148
318 SNEEZING 331 0.0147
319 PRODUCT LABEL CONFUSION 86 0.0147
320 MUSCULOSKELETAL CHEST PAIN 227 0.0147
321 INTERNATIONAL NORMALISED RATIO DECREASED 59 0.0146
322 UPPER RESPIRATORY TRACT CONGESTION 42 0.0145
323 WEIGHT DECREASED 4006 0.0143
324 PLEURAL EFFUSION 869 0.0143
325 COVID-19 PNEUMONIA 168 0.0142
326 FLANK PAIN 133 0.0142
327 HYPERSOMNIA 405 0.0141
328 FEELING ABNORMAL 3361 0.0140
329 IRON DEFICIENCY ANAEMIA 129 0.0140
330 HAEMODYNAMIC INSTABILITY 106 0.0139
331 PULMONARY THROMBOSIS 151 0.0138
332 CARDIAC FAILURE CHRONIC 59 0.0138
333 PRODUCT DISTRIBUTION ISSUE 128 0.0138
334 OESOPHAGEAL DISORDER 53 0.0138
335 MUSCLE STRAIN 119 0.0137
336 VOMITING 6464 0.0137
337 UPPER RESPIRATORY TRACT INFECTION 634 0.0137
338 ILLNESS 1404 0.0136
339 MIGRAINE 1300 0.0136
340 BRONCHITIS 1008 0.0136
341 PRODUCT RESIDUE PRESENT 73 0.0135
342 AMMONIA INCREASED 69 0.0135
343 CREPITATIONS 40 0.0134
344 RED BLOOD CELL COUNT INCREASED 37 0.0134
345 BRONCHOSPASM 191 0.0134
346 POLYURIA 109 0.0133
347 SKIN INFECTION 149 0.0133
348 UNEVALUABLE EVENT 1004 0.0133
349 BRAIN FOG 207 0.0132
350 INFLUENZA 1472 0.0132
351 SWELLING 1234 0.0132
352 CARDIAC DYSFUNCTION 49 0.0132
353 STAPHYLOCOCCAL INFECTION 434 0.0131
354 ATRIAL FIBRILLATION 1264 0.0130
355 MALAISE 5690 0.0130
356 FEELING OF BODY TEMPERATURE CHANGE 76 0.0130
357 ANAL INCONTINENCE 116 0.0129
358 CARDIOPULMONARY FAILURE 50 0.0128
359 LOSS OF CONSCIOUSNESS 1639 0.0128
360 GASTROINTESTINAL DISORDER 1141 0.0127
361 DYSPHONIA 744 0.0127
362 URINE OUTPUT DECREASED 111 0.0127
363 DRUG DOSE OMISSION 2096 0.0127
364 FATIGUE 9810 0.0126
365 FLATULENCE 714 0.0126
366 RESPIRATORY TRACT INFECTION 323 0.0124
367 BLOOD MAGNESIUM DECREASED 107 0.0124
368 NECK PAIN 692 0.0124
369 RESTLESS LEGS SYNDROME 225 0.0124
370 POST PROCEDURAL COMPLICATION 234 0.0122
371 WHEEZING 722 0.0122
372 RESPIRATORY RATE INCREASED 108 0.0122
373 GASTROOESOPHAGEAL REFLUX DISEASE 968 0.0120
374 TRICUSPID VALVE INCOMPETENCE 95 0.0119
375 EAR INFECTION 318 0.0119
376 DEHYDRATION 1592 0.0119
377 DEVICE BREAKAGE 484 0.0119
378 PULMONARY CONGESTION 157 0.0119
379 CANDIDA INFECTION 201 0.0119
380 ASTHENIA 4467 0.0119
381 PRODUCT USE COMPLAINT 187 0.0119
382 SEPSIS 1323 0.0118
383 SINUSITIS 1207 0.0118
384 POOR PERIPHERAL CIRCULATION 50 0.0117
385 SENSITIVE SKIN 86 0.0116
386 DIALYSIS 165 0.0116
387 CARDIAC PACEMAKER INSERTION 69 0.0116
388 GASTROINTESTINAL HAEMORRHAGE 967 0.0116
389 FAILURE TO THRIVE 60 0.0115
390 FEELING JITTERY 220 0.0115
391 CONCOMITANT DISEASE AGGRAVATED 71 0.0115
392 HYPOVOLAEMIA 67 0.0114
393 VIRAL UPPER RESPIRATORY TRACT INFECTION 54 0.0113
394 FAECES DISCOLOURED 246 0.0113
395 TASTE DISORDER 230 0.0113
396 ABDOMINAL PAIN UPPER 2329 0.0113
397 FEELING COLD 314 0.0113
398 TRISMUS 58 0.0112
399 SKIN LACERATION 122 0.0112
400 AORTIC STENOSIS 39 0.0112
401 INTENTIONAL DOSE OMISSION 317 0.0111
402 LIMB INJURY 301 0.0111
403 STENT PLACEMENT 89 0.0110
404 FRUSTRATION TOLERANCE DECREASED 89 0.0110
405 COMPRESSION FRACTURE 59 0.0110
406 ABNORMAL LOSS OF WEIGHT 75 0.0110
407 FACIAL PAIN 98 0.0110
408 APHONIA 153 0.0110
409 TENSION HEADACHE 47 0.0109
410 GASTRIC DISORDER 374 0.0109
411 HAEMATEMESIS 274 0.0108
412 MUSCULOSKELETAL DISCOMFORT 185 0.0107
413 CARDIAC TAMPONADE 51 0.0107
414 WEIGHT INCREASED 2403 0.0107
415 GLOSSITIS 38 0.0107
416 FREQUENT BOWEL MOVEMENTS 289 0.0107
417 HIP FRACTURE 341 0.0106
418 DEATH 9125 0.0106
419 INJECTION SITE VESICLES 64 0.0106
420 FEEDING DISORDER 214 0.0105
421 EAR PAIN 205 0.0105
422 STAPHYLOCOCCAL SEPSIS 52 0.0105
423 CARDIAC DISORDER 984 0.0105
424 POOR QUALITY SLEEP 226 0.0105
425 CARDIAC OPERATION 90 0.0105
426 IRON DEFICIENCY 47 0.0104
427 BLOOD PRESSURE DIASTOLIC DECREASED 77 0.0104
428 MYALGIA 1766 0.0104
429 BACTERIAL INFECTION 193 0.0103
430 LIMB DISCOMFORT 319 0.0103
431 THERAPEUTIC PRODUCT EFFECT VARIABLE 40 0.0103
432 MENTAL STATUS CHANGES 285 0.0103
433 BLOOD PRESSURE FLUCTUATION 246 0.0102
434 INTERNATIONAL NORMALISED RATIO INCREASED 292 0.0102
435 NEURALGIA 249 0.0102
436 MOUTH HAEMORRHAGE 75 0.0102
437 GENERAL PHYSICAL HEALTH DETERIORATION 1183 0.0102
438 HEPATIC CIRRHOSIS 192 0.0102
439 RENAL DISORDER 476 0.0102
440 LETHARGY 587 0.0102
441 TONGUE DISCOMFORT 43 0.0101
442 PRODUCT USE ISSUE 1887 0.0100
443 RESPIRATORY DISORDER 300 0.0100
444 GALLBLADDER DISORDER 179 0.0100
445 TOOTHACHE 181 0.0100
446 PHARYNGITIS STREPTOCOCCAL 108 0.0100
447 HEART RATE DECREASED 349 0.0099
448 FEELING HOT 605 0.0099
449 BACK PAIN 2286 0.0098
450 HYPERVENTILATION 57 0.0098
451 BLOOD SODIUM DECREASED 185 0.0098
452 ELECTROLYTE IMBALANCE 114 0.0098
453 PNEUMONIA BACTERIAL 90 0.0098
454 DRY MOUTH 793 0.0098
455 SICKLE CELL ANAEMIA WITH CRISIS 153 0.0097
456 JAW DISORDER 53 0.0097
457 LUNG INFECTION 150 0.0096
458 PROCEDURAL COMPLICATION 74 0.0096
459 FALL 3205 0.0096
460 DEAFNESS UNILATERAL 53 0.0096
461 PULMONARY FUNCTION TEST DECREASED 42 0.0096
462 COLD SWEAT 167 0.0095
463 POST PROCEDURAL HAEMORRHAGE 110 0.0094
464 CLAVICLE FRACTURE 36 0.0094
465 GINGIVAL BLEEDING 128 0.0094
466 INCREASED UPPER AIRWAY SECRETION 48 0.0093
467 ORAL CANDIDIASIS 123 0.0093
468 ARTHROPOD BITE 69 0.0093
469 HERNIA 180 0.0093
470 ACCIDENTAL OVERDOSE 340 0.0093
471 MUCOUS STOOLS 46 0.0093
472 ERUCTATION 179 0.0092
473 BACK INJURY 100 0.0092
474 AUTOIMMUNE DISORDER 89 0.0091
475 CARDIAC VALVE DISEASE 52 0.0091
476 RIB FRACTURE 187 0.0091
477 INTERSTITIAL LUNG DISEASE 440 0.0091
478 INJECTION SITE INFLAMMATION 45 0.0090
479 ULCER HAEMORRHAGE 61 0.0090
480 BOWEL MOVEMENT IRREGULARITY 69 0.0090
481 PALLOR 244 0.0090
482 CHILLS 1051 0.0090
483 TOOTH INFECTION 118 0.0089
484 SKIN TIGHTNESS 42 0.0089
485 GASTROINTESTINAL INFECTION 80 0.0089
486 MUSCLE TIGHTNESS 144 0.0089
487 PELVIC FRACTURE 69 0.0089
488 EMPHYSEMA 89 0.0088
489 DEVICE ADHESION ISSUE 135 0.0088
490 GASTRIC HAEMORRHAGE 101 0.0088
491 KIDNEY INFECTION 171 0.0087
492 SARS-COV-2 TEST POSITIVE 115 0.0087
493 HAEMOGLOBIN ABNORMAL 56 0.0087
494 ORAL PAIN 194 0.0087
495 CORONAVIRUS INFECTION 57 0.0086
496 PERIPHERAL COLDNESS 118 0.0086
497 HAEMOGLOBIN DECREASED 878 0.0085
498 TOOTH ABSCESS 87 0.0085
499 MUSCULOSKELETAL PAIN 447 0.0085
500 SCIATICA 136 0.0085
501 NERVOUSNESS 445 0.0085
502 HAEMATOCHEZIA 470 0.0085
503 OCULAR DISCOMFORT 95 0.0085
504 FOOD ALLERGY 65 0.0084
505 MULTIPLE ALLERGIES 66 0.0084
506 CONDITION AGGRAVATED 2559 0.0084
507 HOSPITALISATION 1293 0.0084
508 BLOOD COUNT ABNORMAL 127 0.0084
509 DISEASE PROGRESSION 990 0.0084
510 TACHYCARDIA 739 0.0083
511 SYSTEMIC LUPUS ERYTHEMATOSUS 295 0.0083
512 BEDRIDDEN 109 0.0083
513 URINARY TRACT INFECTION 1414 0.0083
514 BLOOD POTASSIUM INCREASED 134 0.0082
515 INFECTION 1194 0.0082
516 THROAT TIGHTNESS 223 0.0082
517 SUBDURAL HAEMATOMA 118 0.0082
518 DIVERTICULITIS 228 0.0082
519 THERAPY INTERRUPTED 588 0.0082
520 CHOKING 160 0.0082
521 PERIORBITAL SWELLING 46 0.0081
522 CONSTIPATION 1765 0.0081
523 SLEEP APNOEA SYNDROME 154 0.0081
524 COVID-19 1409 0.0080
525 INJECTION SITE INDURATION 104 0.0080
526 RECTAL HAEMORRHAGE 342 0.0080
527 MALNUTRITION 89 0.0079
528 ORAL DISCOMFORT 110 0.0079
529 JOINT SWELLING 955 0.0079
530 JOINT INJURY 169 0.0079
531 HOT FLUSH 594 0.0079
532 BLOOD DISORDER 63 0.0079
533 HAEMORRHAGE 821 0.0078
534 ANAEMIA 1484 0.0078
535 DECUBITUS ULCER 63 0.0077
536 PRODUCT DOSE OMISSION ISSUE 2272 0.0077
537 PRODUCT COMMUNICATION ISSUE 68 0.0077
538 SEPTIC SHOCK 335 0.0077
539 MUSCLE SPASMS 1412 0.0077
540 HYPOACUSIS 331 0.0077
541 LIGAMENT SPRAIN 76 0.0077
542 GASTROINTESTINAL SOUNDS ABNORMAL 38 0.0077
543 ABSCESS 122 0.0076
544 PAIN 4697 0.0076
545 ASTHENOPIA 42 0.0076
546 DRUG DELIVERY SYSTEM MALFUNCTION 39 0.0076
547 EXTRA DOSE ADMINISTERED 309 0.0076
548 HOSPICE CARE 75 0.0076
549 PHARYNGEAL SWELLING 74 0.0076
550 UNRESPONSIVE TO STIMULI 195 0.0075
551 LACERATION 71 0.0075
552 LOWER LIMB FRACTURE 145 0.0075
553 LIVER DISORDER 334 0.0075
554 PULMONARY ALVEOLAR HAEMORRHAGE 42 0.0075
555 ASPIRATION 82 0.0075
556 HAEMORRHOIDS 146 0.0075
557 PSEUDOMONAS INFECTION 64 0.0075
558 GASTROINTESTINAL PAIN 82 0.0074
559 ANEURYSM 37 0.0074
560 ANKLE FRACTURE 115 0.0074
561 CLOSTRIDIUM DIFFICILE COLITIS 78 0.0073
562 CARDIAC ARREST 603 0.0073
563 GINGIVAL PAIN 58 0.0073
564 SPINAL FRACTURE 146 0.0073
565 UPPER LIMB FRACTURE 145 0.0073
566 EYE INFECTION 82 0.0073
567 APPETITE DISORDER 48 0.0072
568 PRODUCT DOSE OMISSION 471 0.0072
569 DIARRHOEA HAEMORRHAGIC 67 0.0072
570 POLLAKIURIA 298 0.0071
571 LABORATORY TEST ABNORMAL 208 0.0070
572 PYREXIA 2434 0.0070
573 WRIST FRACTURE 84 0.0070
574 SUDDEN DEATH 74 0.0070
575 THROMBOSIS 558 0.0069
576 ABDOMINAL PAIN 1610 0.0069
577 PULMONARY MASS 102 0.0068
578 INSOMNIA 1820 0.0068
579 GROIN PAIN 60 0.0068
580 ATELECTASIS 66 0.0068
581 BRONCHIECTASIS 46 0.0068
582 HEPATOMEGALY 67 0.0068
583 BONE PAIN 398 0.0068
584 CONTUSION 654 0.0068
585 INFLUENZA LIKE ILLNESS 559 0.0068
586 ARTHRALGIA 2812 0.0068
587 SMALL INTESTINAL OBSTRUCTION 83 0.0067
588 ANXIETY 1915 0.0067
589 SKIN WARM 39 0.0067
590 TEMPERATURE INTOLERANCE 69 0.0067
591 ATRIAL SEPTAL DEFECT 56 0.0067
592 PRODUCT DOSE OMISSION IN ERROR 189 0.0067
593 HEAVY MENSTRUAL BLEEDING 60 0.0067
594 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 114 0.0066
595 GAIT INABILITY 222 0.0066
596 LARGE INTESTINE POLYP 46 0.0066
597 BLOOD TEST ABNORMAL 93 0.0066
598 CONCUSSION 51 0.0066
599 INJECTION SITE ERYTHEMA 816 0.0066
600 PRODUCT PREPARATION ISSUE 43 0.0065
601 BACK DISORDER 106 0.0065
602 SCAB 74 0.0065
603 BODY TEMPERATURE INCREASED 132 0.0065
604 TROPONIN INCREASED 49 0.0064
605 RENAL FAILURE 852 0.0064
606 PANIC ATTACK 233 0.0064
607 INJECTION SITE PRURITUS 427 0.0064
608 GASTROENTERITIS 93 0.0064
609 AGEUSIA 158 0.0063
610 SPINAL COMPRESSION FRACTURE 52 0.0063
611 NERVE COMPRESSION 58 0.0063
612 TOOTH EXTRACTION 78 0.0063
613 ORTHOSTATIC HYPOTENSION 109 0.0063
614 SKIN IRRITATION 284 0.0062
615 HERPES ZOSTER 356 0.0062
616 NO THERAPEUTIC RESPONSE 75 0.0061
617 PRODUCT PHYSICAL ISSUE 124 0.0061
618 HYPOKALAEMIA 283 0.0061
619 FACE OEDEMA 103 0.0061
620 PANIC REACTION 44 0.0061
621 RASH PRURITIC 330 0.0061
622 SWELLING FACE 393 0.0060
623 POST PROCEDURAL INFECTION 49 0.0060
624 EYE HAEMORRHAGE 80 0.0060
625 ARTHRITIS 469 0.0060
626 POLYP 39 0.0060
627 PHOTOPHOBIA 112 0.0059
628 SENSATION OF FOREIGN BODY 50 0.0059
629 THIRST 106 0.0059
630 INJECTION SITE RASH 182 0.0059
631 LYMPHOEDEMA 41 0.0059
632 HYPERHIDROSIS 759 0.0059
633 EATING DISORDER 125 0.0059
634 WOUND 164 0.0059
635 DEFAECATION URGENCY 41 0.0058
636 PRODUCT ADMINISTRATION ERROR 118 0.0058
637 TREMOR 967 0.0058
638 MULTIPLE ORGAN DYSFUNCTION SYNDROME 165 0.0058
639 SKIN DISCOLOURATION 266 0.0058
640 INTESTINAL OBSTRUCTION 218 0.0058
641 ARRHYTHMIA 273 0.0058
642 INCOHERENT 37 0.0057
643 SOMNOLENCE 1151 0.0057
644 HAEMATOMA 148 0.0057
645 IRRITABLE BOWEL SYNDROME 122 0.0057
646 HEPATIC ENCEPHALOPATHY 53 0.0057
647 WOUND INFECTION 62 0.0057
648 INJECTION SITE HAEMORRHAGE 452 0.0057
649 TINNITUS 260 0.0057
650 DEPRESSED MOOD 298 0.0056
651 CYSTITIS 179 0.0056
652 FULL BLOOD COUNT DECREASED 113 0.0056
653 DEAFNESS 146 0.0056
654 SKIN ULCER 144 0.0056
655 COLON CANCER 83 0.0056
656 APPENDICITIS 52 0.0056
657 CARDIAC MURMUR 48 0.0055
658 LOWER GASTROINTESTINAL HAEMORRHAGE 41 0.0055
659 HYSTERECTOMY 48 0.0055
660 UROSEPSIS 51 0.0055
661 LACRIMATION INCREASED 167 0.0055
662 FUNGAL INFECTION 184 0.0055
663 INJECTION SITE DISCOMFORT 58 0.0055
664 EYE SWELLING 204 0.0055
665 ROAD TRAFFIC ACCIDENT 229 0.0055
666 VISION BLURRED 750 0.0055
667 THYROID DISORDER 84 0.0054
668 EXTRASYSTOLES 38 0.0054
669 SCRATCH 57 0.0054
670 NIGHT SWEATS 174 0.0054
671 SALIVARY HYPERSECRETION 54 0.0054
672 INSURANCE ISSUE 82 0.0054
673 BLADDER DISORDER 53 0.0053
674 MOBILITY DECREASED 383 0.0053
675 HIATUS HERNIA 69 0.0053
676 MUSCULAR WEAKNESS 599 0.0053
677 ERYTHEMA 1079 0.0052
678 ABNORMAL FAECES 43 0.0052
679 INCONTINENCE 55 0.0052
680 SCAR 89 0.0052
681 HAEMATOCRIT DECREASED 103 0.0052
682 IMPAIRED GASTRIC EMPTYING 70 0.0051
683 BURNING SENSATION 359 0.0051
684 FOOT FRACTURE 97 0.0051
685 BLOOD URINE PRESENT 97 0.0051
686 OFF LABEL USE 4466 0.0051
687 ELECTROCARDIOGRAM ABNORMAL 40 0.0051
688 GAIT DISTURBANCE 975 0.0051
689 GLOSSODYNIA 114 0.0051
690 ULCER 81 0.0051
691 TENDERNESS 53 0.0051
692 CARDIO-RESPIRATORY ARREST 212 0.0051
693 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 912 0.0051
694 HYPOAESTHESIA ORAL 76 0.0050
695 PAROSMIA 38 0.0050
696 BLOOD PRESSURE SYSTOLIC INCREASED 98 0.0050
697 INCORRECT DOSE ADMINISTERED BY DEVICE 131 0.0050
698 QUALITY OF LIFE DECREASED 67 0.0050
699 ESCHERICHIA INFECTION 41 0.0050
700 PLATELET COUNT DECREASED 531 0.0050
701 ADVERSE EVENT 458 0.0050
702 HYPOPHAGIA 127 0.0050
703 SHOCK 114 0.0050
704 CHOLECYSTITIS 59 0.0049
705 MITRAL VALVE INCOMPETENCE 56 0.0049
706 INJECTION SITE EXTRAVASATION 61 0.0049
707 OSTEOMYELITIS 89 0.0049
708 PRODUCT CONTAINER ISSUE 42 0.0049
709 VITREOUS FLOATERS 48 0.0049
710 LYMPHADENOPATHY 172 0.0049
711 INCORRECT DOSE ADMINISTERED 1109 0.0049
712 CHOLELITHIASIS 159 0.0048
713 BLOOD PRESSURE INCREASED 741 0.0048
714 VENTRICULAR TACHYCARDIA 80 0.0048
715 HEPATIC FAILURE 145 0.0048
716 SPLENOMEGALY 56 0.0048
717 BALANCE DISORDER 413 0.0048
718 PHARYNGITIS 59 0.0048
719 CATARACT 283 0.0047
720 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 228 0.0047
721 BLOOD GLUCOSE DECREASED 227 0.0047
722 MELAENA 104 0.0047
723 DYSGEUSIA 351 0.0047
724 INJECTION SITE DISCOLOURATION 59 0.0047
725 OCULAR HYPERAEMIA 223 0.0047
726 UPPER GASTROINTESTINAL HAEMORRHAGE 78 0.0046
727 TACHYPNOEA 63 0.0046
728 TOOTH DISORDER 103 0.0046
729 MOOD ALTERED 126 0.0046
730 MEMORY IMPAIRMENT 631 0.0046
731 URINARY INCONTINENCE 136 0.0046
732 RHINITIS 37 0.0046
733 EYE PAIN 258 0.0046
734 INCREASED TENDENCY TO BRUISE 42 0.0046
735 LIVER FUNCTION TEST INCREASED 98 0.0046
736 DISCOMFORT 277 0.0045
737 RENAL PAIN 48 0.0045
738 VERTIGO 275 0.0045
739 VISUAL IMPAIRMENT 556 0.0045
740 HYPOAESTHESIA 670 0.0045
741 TOOTH FRACTURE 49 0.0044
742 LUNG INFILTRATION 39 0.0044
743 LOCAL SWELLING 77 0.0044
744 CEREBRAL HAEMORRHAGE 157 0.0044
745 CONFUSIONAL STATE 708 0.0044
746 MICTURITION URGENCY 50 0.0044
747 PNEUMONITIS 119 0.0044
748 DEVICE DIFFICULT TO USE 289 0.0044
749 NEPHROLITHIASIS 200 0.0044
750 CARPAL TUNNEL SYNDROME 61 0.0044
751 INABILITY TO AFFORD MEDICATION 43 0.0043
752 HYPERTENSION 905 0.0043
753 ACCIDENT 51 0.0043
754 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 199 0.0043
755 PULMONARY EMBOLISM 403 0.0042
756 INJECTION SITE SWELLING 321 0.0042
757 RASH MACULAR 146 0.0042
758 PARAESTHESIA ORAL 60 0.0042
759 HYPERTHYROIDISM 60 0.0041
760 PARAESTHESIA 651 0.0041
761 BREAST PAIN 44 0.0041
762 LUNG NEOPLASM MALIGNANT 169 0.0041
763 DYSSTASIA 120 0.0041
764 GASTRITIS 108 0.0041
765 BRAIN INJURY 41 0.0041
766 INJECTION SITE WARMTH 83 0.0040
767 EXPOSURE VIA SKIN CONTACT 104 0.0040
768 PNEUMONIA ASPIRATION 100 0.0040
769 SLEEP DISORDER 282 0.0040
770 BLISTER 224 0.0040
771 CHROMATURIA 90 0.0040
772 SKIN HAEMORRHAGE 59 0.0040
773 LIVER FUNCTION TEST ABNORMAL 115 0.0040
774 MUSCLE ATROPHY 50 0.0039
775 CHOLECYSTECTOMY 45 0.0039
776 RESPIRATORY ARREST 108 0.0039
777 IMPAIRED QUALITY OF LIFE 56 0.0039
778 PREMATURE DELIVERY 62 0.0039
779 ACUTE KIDNEY INJURY 594 0.0039
780 CORONARY ARTERY OCCLUSION 53 0.0039
781 MACULAR DEGENERATION 46 0.0038
782 RASH ERYTHEMATOUS 184 0.0038
783 LOWER RESPIRATORY TRACT INFECTION 175 0.0038
784 NEUROPATHY PERIPHERAL 363 0.0038
785 DERMATITIS ALLERGIC 48 0.0038
786 HYPOTONIA 38 0.0038
787 RESTLESSNESS 139 0.0038
788 ACUTE RESPIRATORY DISTRESS SYNDROME 67 0.0038
789 INJECTION SITE PAIN 1162 0.0038
790 DYSURIA 138 0.0037
791 PROCEDURAL PAIN 104 0.0037
792 SKIN DISORDER 124 0.0037
793 DENTAL CARIES 41 0.0037
794 SKIN REACTION 52 0.0037
795 PRURITUS 1403 0.0036
796 CIRCULATORY COLLAPSE 62 0.0036
797 TRANSIENT ISCHAEMIC ATTACK 122 0.0036
798 RENAL IMPAIRMENT 303 0.0036
799 INITIAL INSOMNIA 37 0.0036
800 HYPERSENSITIVITY 666 0.0036
801 GASTRIC ULCER 68 0.0036
802 MASS 50 0.0036
803 WHITE BLOOD CELL COUNT INCREASED 137 0.0036
804 MENORRHAGIA 70 0.0036
805 DYSPHAGIA 337 0.0035
806 RED BLOOD CELL COUNT DECREASED 100 0.0035
807 OESOPHAGITIS 38 0.0035
808 ENCEPHALOPATHY 85 0.0035
809 INTENTIONAL PRODUCT USE ISSUE 303 0.0035
810 PRODUCT PREPARATION ERROR 71 0.0035
811 APPLICATION SITE PRURITUS 78 0.0034
812 MENTAL IMPAIRMENT 83 0.0034
813 PREMATURE BABY 103 0.0034
814 HAEMORRHAGE INTRACRANIAL 51 0.0034
815 DISORIENTATION 135 0.0034
816 BLOOD CREATININE INCREASED 222 0.0034
817 HIP ARTHROPLASTY 52 0.0034
818 SEIZURE 392 0.0034
819 PHOTOSENSITIVITY REACTION 56 0.0034
820 ABDOMINAL PAIN LOWER 85 0.0034
821 DEVICE DEFECTIVE 58 0.0033
822 PERICARDITIS 56 0.0033
823 PRURITUS GENERALISED 72 0.0033
824 INCREASED APPETITE 63 0.0033
825 IMPAIRED HEALING 108 0.0033
826 ROTATOR CUFF SYNDROME 42 0.0033
827 SINUS TACHYCARDIA 46 0.0032
828 RASH 1409 0.0032
829 ADVERSE DRUG REACTION 290 0.0032
830 NEOPLASM MALIGNANT 215 0.0032
831 IRRITABILITY 193 0.0032
832 DIPLOPIA 83 0.0032
833 CAESAREAN SECTION 37 0.0032
834 JOINT STIFFNESS 83 0.0032
835 EYE DISORDER 104 0.0032
836 EYE PRURITUS 106 0.0032
837 AMNESIA 205 0.0031
838 ANGINA PECTORIS 90 0.0031
839 FEMUR FRACTURE 97 0.0031
840 MULTI-ORGAN FAILURE 54 0.0031
841 COAGULOPATHY 52 0.0031
842 ANOSMIA 45 0.0031
843 BLOOD UREA INCREASED 52 0.0031
844 VAGINAL HAEMORRHAGE 134 0.0031
845 CEREBROVASCULAR ACCIDENT 522 0.0031
846 ACTIVITIES OF DAILY LIVING IMPAIRED 61 0.0031
847 ASTHMA 348 0.0031
848 THERAPEUTIC RESPONSE DECREASED 186 0.0031
849 NODULE 40 0.0031
850 BLOOD ALKALINE PHOSPHATASE INCREASED 76 0.0031
851 NEEDLE ISSUE 89 0.0031
852 BLOOD GLUCOSE ABNORMAL 56 0.0030
853 MYOCARDIAL INFARCTION 525 0.0030
854 LIP SWELLING 100 0.0030
855 CYST 37 0.0030
856 COLITIS 113 0.0030
857 SPEECH DISORDER 156 0.0030
858 SURGERY 174 0.0030
859 END STAGE RENAL DISEASE 54 0.0030
860 THINKING ABNORMAL 55 0.0029
861 HUNGER 41 0.0029
862 APPLICATION SITE IRRITATION 36 0.0029
863 BLOOD BILIRUBIN INCREASED 78 0.0029
864 IMMUNE SYSTEM DISORDER 38 0.0029
865 ACUTE MYOCARDIAL INFARCTION 85 0.0029
866 PANCREATITIS 152 0.0029
867 INTERVERTEBRAL DISC PROTRUSION 62 0.0028
868 BRADYCARDIA 150 0.0028
869 PHARYNGEAL OEDEMA 43 0.0028
870 HYPONATRAEMIA 157 0.0028
871 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 561 0.0028
872 STOMATITIS 167 0.0028
873 MUSCLE TWITCHING 63 0.0027
874 DEMENTIA 76 0.0027
875 DEPRESSION 616 0.0027
876 PREGNANCY 54 0.0027
877 INFLAMMATION 139 0.0027
878 FIBROMYALGIA 65 0.0027
879 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 188 0.0026
880 CRYING 96 0.0026
881 SYRINGE ISSUE 46 0.0026
882 APATHY 38 0.0026
883 DEVICE DELIVERY SYSTEM ISSUE 70 0.0026
884 MENTAL DISORDER 110 0.0025
885 APPLICATION SITE ERYTHEMA 66 0.0025
886 ORAL HERPES 49 0.0025
887 URTICARIA 420 0.0025
888 THROMBOCYTOPENIA 280 0.0025
889 ASPARTATE AMINOTRANSFERASE INCREASED 133 0.0025
890 GLAUCOMA 48 0.0025
891 MIDDLE INSOMNIA 46 0.0025
892 RASH GENERALISED 63 0.0024
893 HYPERKALAEMIA 85 0.0024
894 MUSCULOSKELETAL STIFFNESS 211 0.0024
895 LYMPHOMA 37 0.0024
896 FRACTURE 45 0.0024
897 APPLICATION SITE PAIN 50 0.0023
898 ARTHROPATHY 126 0.0023
899 PRODUCT AVAILABILITY ISSUE 51 0.0022
900 DRY SKIN 297 0.0022
901 CONJUNCTIVITIS 41 0.0022
902 DYSARTHRIA 81 0.0021
903 EMOTIONAL DISORDER 66 0.0021
904 OSTEOPOROSIS 88 0.0021
905 DRUG ADMINISTRATION ERROR 65 0.0021
906 DIABETES MELLITUS 161 0.0021
907 MATERNAL EXPOSURE DURING PREGNANCY 188 0.0021
908 ABASIA 52 0.0021
909 RASH PAPULAR 47 0.0021
910 ILL-DEFINED DISORDER 127 0.0021
911 URINARY RETENTION 69 0.0021
912 BLINDNESS 84 0.0021
913 ACCIDENTAL EXPOSURE TO PRODUCT 209 0.0020
914 DRY EYE 101 0.0020
915 DISTURBANCE IN ATTENTION 109 0.0020
916 FEAR 54 0.0020
917 OVERDOSE 433 0.0020
918 HEPATIC CANCER 48 0.0020
919 SKIN CANCER 42 0.0019
920 HEPATIC ENZYME INCREASED 131 0.0019
921 DERMATITIS 40 0.0019
922 INJECTION SITE REACTION 128 0.0019
923 CORONARY ARTERY DISEASE 56 0.0018
924 EYE IRRITATION 106 0.0018
925 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 131 0.0018
926 RENAL FAILURE ACUTE 78 0.0018
927 ALANINE AMINOTRANSFERASE INCREASED 112 0.0018
928 PAIN OF SKIN 48 0.0018
929 EXPIRED PRODUCT ADMINISTERED 59 0.0018
930 DEEP VEIN THROMBOSIS 114 0.0018
931 HYPOGLYCAEMIA 85 0.0018
932 HAEMATURIA 60 0.0018
933 ABNORMAL DREAMS 48 0.0017
934 AGITATION 127 0.0017
935 ALOPECIA 334 0.0017
936 SKIN LESION 46 0.0017
937 DELIRIUM 58 0.0017
938 SWOLLEN TONGUE 52 0.0017
939 APHASIA 50 0.0017
940 BLOOD GLUCOSE INCREASED 302 0.0016
941 DYSKINESIA 65 0.0016
942 PRODUCT ADHESION ISSUE 57 0.0016
943 THERAPEUTIC RESPONSE UNEXPECTED 70 0.0016
944 HALLUCINATION 117 0.0016
945 RHEUMATOID ARTHRITIS 176 0.0015
946 ECZEMA 81 0.0015
947 INJECTION SITE BRUISING 122 0.0015
948 HEPATIC FUNCTION ABNORMAL 57 0.0015
949 INJECTION SITE MASS 56 0.0015
950 EXPOSURE DURING PREGNANCY 94 0.0015
951 COMA 69 0.0014
952 OSTEOARTHRITIS 60 0.0014
953 SKIN EXFOLIATION 119 0.0014
954 MOVEMENT DISORDER 45 0.0014
955 NIGHTMARE 48 0.0014
956 HYPOTHYROIDISM 44 0.0014
957 DRUG INTERACTION 218 0.0014
958 CHRONIC KIDNEY DISEASE 103 0.0014
959 SKIN BURNING SENSATION 97 0.0014
960 UNDERDOSE 93 0.0013
961 DRUG INEFFECTIVE 1634 0.0012
962 HYPERGLYCAEMIA 45 0.0012
963 COLITIS ULCERATIVE 55 0.0012
964 INJURY 84 0.0012
965 MOOD SWINGS 38 0.0012
966 NERVOUS SYSTEM DISORDER 37 0.0012
967 COGNITIVE DISORDER 55 0.0012
968 PRODUCT USE IN UNAPPROVED INDICATION 285 0.0011
969 WHITE BLOOD CELL COUNT DECREASED 123 0.0011
970 THERAPEUTIC RESPONSE SHORTENED 37 0.0011
971 PANCYTOPENIA 62 0.0011
972 MEDICATION ERROR 58 0.0010
973 DEPRESSED LEVEL OF CONSCIOUSNESS 41 0.0010
974 ABNORMAL BEHAVIOUR 41 0.0010
975 BREAST CANCER 84 0.0009
976 FOETAL EXPOSURE DURING PREGNANCY 73 0.0009
977 CONVULSION 50 0.0009
978 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 47 0.0009
979 ANGIOEDEMA 37 0.0008
980 PRODUCT QUALITY ISSUE 110 0.0008
981 ACNE 59 0.0008
982 SUICIDAL IDEATION 69 0.0008
983 PRODUCT SUBSTITUTION ISSUE 41 0.0007
984 TREATMENT FAILURE 58 0.0007
985 ANAPHYLACTIC REACTION 38 0.0007
986 DRUG ABUSE 53 0.0006
987 BLADDER CANCER 37 0.0006
988 INTENTIONAL PRODUCT MISUSE 54 0.0006
989 TOXICITY TO VARIOUS AGENTS 90 0.0005
990 PRODUCT STORAGE ERROR 46 0.0005
991 EMOTIONAL DISTRESS 60 0.0005
992 DRUG WITHDRAWAL SYNDROME 39 0.0004
993 NO ADVERSE EVENT 77 0.0004
994 PSORIASIS 44 0.0003